• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Microbiol Infect . Congenital infection of SARS-CoV-2 in live-born neonates: a population-based descriptive study

tetano

Editor, Senior Moderator
Clin Microbiol Infect


. 2021 Jun 18;S1198-743X(21)00336-0.
doi: 10.1016/j.cmi.2021.06.016. Online ahead of print.
Congenital infection of SARS-CoV-2 in live-born neonates: a population-based descriptive study


Itziar Garcia-Ruiz[SUP] 1 [/SUP], Elena Sulleiro[SUP] 2 [/SUP], Berta Serrano[SUP] 1 [/SUP], Irene Fernandez-Buhigas[SUP] 3 [/SUP], Leire Rodriguez-Gomez[SUP] 4 [/SUP], David Sanchez-Nieves[SUP] 5 [/SUP], Andrés Anton-Pagarolas[SUP] 2 [/SUP], Juliana Esperalba-Esquerra[SUP] 2 [/SUP], Marie Antoinette Frick[SUP] 6 [/SUP], Fatima Camba[SUP] 7 [/SUP], Alexandra Navarro-Jimenez[SUP] 8 [/SUP], Nuria Fernandez-Hidalgo[SUP] 9 [/SUP], Nerea Maiz[SUP] 10 [/SUP], Elena Carreras[SUP] 1 [/SUP], Anna Suy[SUP] 1 [/SUP], GESTACOVID Collaborative Group



Collaborators, Affiliations

Abstract

Objective: This study aimed to evaluate the evidence of mother-to-child transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Methods: This is a descriptive, multicenter, observational study in nine tertiary care hospitals throughout Spain. The study population was women with COVID-19 during pregnancy. Mother-to-child transmission was defined as positive real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) of SARS-CoV-2 in amniotic fluid, cord blood, placenta or neonatal nasopharyngeal swabs taken immediately after birth.
Results: We included 43 singleton pregnant women and one twin pregnancy, thus we obtained 45 samples of placenta, amniotic fluid and umbilical cord blood. The median gestational age at diagnosis was 34.7 weeks (range 14 to 41.3). The median interval between positive RT-PCR and delivery was 21.5 days (range 0 to 141 days). Fourteen women (31.8%, 95%CI 18.6-47.6%) were positive at the time of delivery. There was one singleton pregnancy with SARS-CoV-2 RT-PCR positive in the placenta, amniotic fluid and umbilical cord blood (2.2%, 95%CI 0.1-11.8%). Nasopharyngeal aspiration was performed on 38 neonates at birth, all of which were negative (0%, 95%CI 0-9.3%). In 11 neonates the nasopharyngeal aspiration was repeated at 24-48 hours, and one returned positive (9.1%, 95%CI 0.2-41.3%).
Conclusions: The presence of the SARS-CoV-2 in placenta, amniotic fluid and cord blood shows that mother-to-child transmission is possible but uncommon.

Keywords: COVID-19; Congenital infection; Coronavirus; Mother-to-child transmission; Pregnancy; SARS-CoV-2.
 
Back
Top Bottom